CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PC1UZ37

Market Closed - Boerse Frankfurt Warrants 03:40:22 2024-07-12 pm EDT
99.81 EUR -0.39% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-1.11%
1 month-0.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 99.94 -0.26%
24-07-11 100.2 -0.01%
24-07-10 100.2 +0.08%
24-07-09 100.1 +0.26%
24-07-08 99.87 +0.04%

Real-time Boerse Frankfurt Warrants

Last update July 12, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1UZ3
ISINDE000PC1UZ37
Date issued 2023-12-13
Strike 120 $
Maturity 2025-12-19 (524 Days)
Parity 1 : 1
Emission price 85.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 102.1
Lowest since issue 88.18
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.8 USD
Average target price
142.6 USD
Spread / Average Target
+11.59%
Consensus